Correspondingly, recent studies have also reported no significant effects of APOE4 on cognitive performance in PD subjects during the early stages of the disease, which is consistent with the absence of cognitive differences between the PD APOE4 carriers and non-carriers in our study [54]. Here, APOE is linked to Parkinson disease.